This test is most useful if any of these apply to you.
If you sneeze around horses, get itchy at the stable, or struggle with asthma that flares after riding lessons, the question is usually which part of the horse your body is reacting to. Standard allergy panels often lump horse dander into a single result, which can miss people whose immune system targets specific horse proteins.
This test looks at one of those specific proteins, called Equ c 4. Equ c 4 is latherin, a surfactant protein made in horse sweat and salivary glands that ends up on horse skin and dander. Knowing whether your body makes antibodies against this particular target can help explain symptoms that don't fit a simple pattern, and it can guide decisions about exposure, treatment, and which other tests to run next.
Equ c 4 IgE measures a type of immune antibody (called IgE) that your body produces when it sees Equ c 4 (latherin), a protein from horse sweat and saliva that coats horse skin and dander, as a threat. When you encounter horse dander again, those antibodies trigger the cells that release the chemicals behind sneezing, itching, hives, and asthma.
This is a research and component-level test rather than a one-number diagnosis. It belongs to a family of tools called component-resolved diagnostics, which break a single allergy source down into its individual proteins. A standard horse dander panel gives you a yes-or-no answer. A component test like this one tells you which specific molecule your immune system is responding to.
Component testing for horse allergy is still maturing. The largest direct study of microarrayed horse allergens included only two horse proteins, Equ c 1 and Equ c 3. Among 11 people with clear horse-related symptoms, only 6 had IgE to one or both of those proteins, meaning roughly half of clearly horse-allergic patients were missed by the two components on the chip.
The authors concluded that more horse allergen components, potentially including ones like Equ c 4, are needed to capture all horse-allergic people. That gap is exactly the kind of blind spot a single-component test like Equ c 4 IgE is built to address. If your reaction is driven by Equ c 4, a panel that only measures Equ c 1 or whole-extract horse dander could come back negative while your symptoms are real.
In a study of 1,822 urban allergy patients with no occupational horse exposure, 3.43% of the skin-prick-test-positive subset (1,201 patients) were sensitized to horse dander. Many had rhinitis (runny nose, congestion), asthma, or both. This is higher than most people would expect for a population that doesn't live or work around horses, and it suggests that horse allergens travel further than direct contact.
Sensitization in that study was confirmed through specific IgE to horse dander extract and to individual horse proteins. The takeaway is practical: you don't need to ride or own a horse to develop a meaningful immune response to horse dander, and you don't need direct exposure for symptoms to interfere with daily life.
Equ c 4 is latherin, a member of the PLUNC family of surfactant proteins, not a lipocalin. So the broader lipocalin-asthma data do not directly apply to Equ c 4. The horse lipocalin allergens are Equ c 1 and Equ c 2, which are different proteins covered by separate tests.
For context, studies of furry animal allergy have linked sensitization to animal lipocalins with asthma severity. In 95 children with severe asthma, IgE to multiple animal lipocalins was associated with greater bronchial inflammation. In 59 dog-dander-sensitized children, high IgE to dog lipocalins was associated with more severe asthma. These findings inform the value of testing the lipocalin horse components (Equ c 1 and Equ c 2) alongside Equ c 4, but they should not be read as direct evidence about Equ c 4 itself.
Horse, cat, and dog allergens share certain protein families, which is why some people react to multiple animals without ever being exposed to all of them. In a study of 95 furry-animal-allergic patients, serum albumin proteins (a different horse component called Equ c 3) showed the strongest cross-reactivity between species.
Equ c 4 (latherin) is structurally different. It belongs to the PLUNC family of surfactant proteins, which are largely unique to equids. Clustering analyses of component sensitization patterns have found that Equ c 4 IgE tends to separate from cross-reactive lipocalin and albumin groups, supporting its role as a marker of genuine, horse-specific sensitization. In plain terms: a positive Equ c 4 result is more likely to reflect a real reaction to horse proteins than spillover from a cat or dog allergy. That makes it useful for sorting out whether your symptoms around horses are driven by horse proteins directly or by cross-reactive proteins shared with pets you already know you react to.
A positive IgE result does not automatically mean you have allergic disease. Studies of allergen-specific IgE testing consistently show that some people have antibodies in their blood without any clinical symptoms, and a smaller number have clear symptoms despite negative tests.
This is not paradoxical once you understand the framework. IgE measures whether your immune system has been primed to recognize an allergen. Whether that priming translates into runny noses, hives, or asthma depends on how much exposure you get, how reactive your tissues are, and what other allergens you're already managing. The test tells you about the immune signal, not whether that signal is currently causing trouble. Interpret the result in the context of your actual symptoms.
One reading of Equ c 4 IgE is a snapshot. Allergen-specific IgE levels can shift over months and years based on exposure patterns, immune therapy, and natural changes in immune reactivity. In general, evidence from immunotherapy studies shows that allergen-specific IgE often rises in the first weeks or months of treatment and then declines slowly over years, while blocking antibodies of the IgG4 type increase.
If you are starting horse allergen immunotherapy, reducing horse exposure, or just trying to understand whether your sensitization is climbing or fading, get a baseline, then retest in 6 to 12 months. After that, annual or every-other-year retesting is reasonable. A single number is hard to act on; a trend gives you signal you can use.
A few categories of factors can distort a single Equ c 4 IgE reading or its interpretation:
If your Equ c 4 IgE is positive and you have symptoms around horses, the next step is usually to complete the horse allergen component picture. That means testing for Equ c 1 (the major horse lipocalin) and Equ c 3 (horse serum albumin) if you haven't already, plus a standard horse dander extract test for comparison. The combination tells you whether your reaction is species-specific or shared with cats and dogs.
If your result is positive but you have no symptoms, the immediate action is to flag it, not to act on it. Document the result, monitor for symptoms with future exposure, and consider rechecking in a year. If you have respiratory symptoms (especially asthma) and multiple positive animal component tests, a referral to an allergist for component-resolved workup and discussion of immunotherapy is reasonable. The combination of positive component IgE plus clear clinical symptoms is what drives treatment decisions, not the lab number alone.
Evidence-backed interventions that affect your Horse, Epithel (Equ c 4) IgE level
Horse, Epithel (Equ c 4) IgE is best interpreted alongside these tests.
Horse, Epithel (Equ c 4) IgE is included in these pre-built panels.